cognisoft.info

What It Is

CABPad is an iPad app from Cognisoft ApS. Its full name is Cognitive Assessment at Bedside using iPad, and it is positioned as a short bedside neuropsychological test battery for post-stroke cognitive impairment. It is designed for subacute stroke patients, with an emphasis on shorter testing time, bedside usability, and reducing the impact of patient fatigue on assessment results.

Core Features and Clinical Design

In terms of functionality, CABPad covers common post-stroke issues, including naming, comprehension, and verbal fluency related to aphasia; visual and directional assessments related to hemispatial neglect; and anosognosia scoring. It also evaluates abilities relevant to independent living, such as working memory, episodic memory, mental speed, focused attention, executive inhibition, and cognitive flexibility. The app includes multiple specific tests, such as Arrow Stroop, symbol digit coding, visual location memory, and the Baking Tray Test, and supports standardized instructions read aloud by the iPad. Its nonverbal memory and executive function tests, as well as its arrow cue design, help reduce interference from aphasia and neglect during testing.

Pricing, Deployment, and Enterprise Capabilities

The website does not disclose plans, licensing fees, purchase channels, free trials, or payment methods. On deployment, the only confirmed information is that it is an iPad app; there is no indication of whether it offers a cloud backend, a self-hosted version, centralized management, or data synchronization. There is also no public information on third-party integrations, APIs, developer support, team collaboration, or permission management. As a result, healthcare institutions that want to connect it to electronic medical records, research databases, or in-house identity systems will need to confirm these capabilities directly with the vendor.

Data Security and Compliance

The page only states that the website does not provide medical advice, diagnosis, or treatment, and notes that the software is proprietary. The text does not disclose how patient data is stored, whether it is encrypted, whether audit logs are supported, or whether it complies with GDPR, medical device regulations, or local healthcare data rules. Given its use in clinical cognitive assessment, buyers should carefully verify the privacy policy, data processing agreement, and healthcare compliance requirements for their region before procurement.

Pros, Cons, and Best-Fit Users

Its strengths are a focused clinical use case, test items designed around common post-stroke cognitive symptoms, and support from preliminary validation studies and normative references. Multilingual support also makes it more suitable for use across regions. The drawbacks are limited transparency around commercial, technical, and compliance details. Unlike a typical SaaS platform, it does not present account management, permissions, integrations, or service support in detail. It is better suited for stroke units, neuropsychology departments, and rehabilitation medicine teams that need standardized bedside screening, rather than as an enterprise platform for direct procurement where information-system integration capabilities are already clearly documented.

Access in China and Alternatives

Access from China cannot be determined from the available text alone. For use in Chinese medical settings, buyers should also confirm the app acquisition channel, network dependencies, payment methods, Chinese language support, and medical compliance. Alternative options include localized cognitive assessment systems, existing hospital rehabilitation assessment software, and digital implementations of licensed paper-and-pencil scales.